Chest pain is a common complaint in all health care settings and can be caused by a wide range of conditions -- from diseases with favorable prognosis like musculoskeletal disorders to acute and potentially life-threatening conditions like coronary heart disease ([@R1]). Most patients with chest pain are initially seen by their general practitioner (GP) who faces the challenge to triage them. To fulfill this task, GPs need to know the relevant etiologies and their respective frequencies. In an intuitive process of probabilistic reasoning GPs combine the initial likelihood for a given etiology (pre-test probability) with their findings from the patient's history and the clinical examination in order to reach a final or at least tentative diagnosis (post-test probability) ([@R2],[@R3]).

Important information is provided by studies of symptoms, which investigate patients presenting with a defined symptom in a health care setting. In particular, they ([@R4]) aim to answer three main questions: How often do patients present with the respective symptom? What are the underlying conditions and their respective frequencies? What is the prognosis of these patients? While in the medical literature there are many studies on effects of treatment, causation of disease, or on diagnostic tests, studies of symptoms are not performed as often. As the results of single studies can show large variations, it is desirable to summarize existing information in a systematic review.

Therefore, we conducted a systematic review of studies investigating the symptom of chest pain in primary care. Since knowledge of relevant etiologies and their respective frequencies has the highest practical value for clinicians, we confine the current article to the reporting on this research question.

Methods
=======

Search strategy and study selection
-----------------------------------

Eligible studies had to recruit unselected primary care patients presenting with chest pain as primary or secondary complaint. We excluded studies in which patients were recruited in secondary or tertiary health care settings. The studies had to recruit all chest pain patients regardless of the likelihood of a specific condition as the underlying etiology and had to report data on the frequency of at least one specific underlying condition.

We conducted comprehensive searches in PubMed (until October 2010) and EMBASE (until March 2011). We used search terms "chest pain" and "primary care." Search strategies included subject headings (MeSH, Embtree) as well as free-text terms and were restricted to English and German (Supplementary material 1[(web extra material 1)](#S1){ref-type="supplementary-material"}). We conducted a hand search in the online published abstracts of the annual meetings of the North American Primary Care Research Group and the European General Practice Research Network. We checked the reference lists of all relevant articles and asked experts in the field if they were aware of studies which were unpublished or ongoing.

Two reviewers independently screened all identified titles and abstracts for inclusion. If uncertainty remained, full-text articles were retrieved and comprehensively assessed for eligibility. Reviewers resolved any disagreements by consensus.

Data extraction and quality assessment
--------------------------------------

One reviewer extracted data on study and patients' characteristics and data on the frequencies of underlying etiologies following a pre-specified and standardized protocol. Currently there is no established approach to assess the risk of bias in studies of symptoms. We developed a risk of bias tool based on the sparse methodological literature ([@R4],[@R5]) and own previous experience in the area ([@R6],[@R7]). Two reviewers independently assessed the risk of bias separately for three key domains: selection of patients and GPs, data collection and patient flow, and determination of the underlying etiology. For each domain reviewers had to answer pre-specified and standardized signaling questions addressing relevant aspects of study design related to the potential of bias. The answers to these questions helped them to reach a judgement on the risk of bias in each domain. These were not, however, used as a score. A description of the risk of bias tool and details of the risk of bias assessment of the primary studies are available in Supplementary material 2[(web extra material 2)](#S2){ref-type="supplementary-material"}. In addition, we assessed whether study-specific inclusion criteria may have introduced clinical heterogeneity or variation, eg, we assumed that a study recruiting patients of all age groups would demonstrate different frequencies of the underlying conditions than a study recruiting patients aged \>35 years.

Analysis and data synthesis
---------------------------

We aimed to estimate how often chest pain was caused by a particular condition. We did not expect that all studies provided data on all diagnostic categories or conditions. For example, studies might have focused on one particular etiology or might have used definitions that did not match definitions used in other studies. Therefore, if a study did not provide data on a particular diagnostic category, we did not consider it in the analysis of this category rather than assuming a relative frequency of 0% with respect to that category. For each study presenting data for a particular condition we calculated the respective proportion and the 95% confidence interval using the Wilson procedure with a correction for continuity ([@R8]). We expected substantial between-study variation that is not due to chance. Variations in study design and risk of bias may cause methodological heterogeneity, while, eg, differences in inclusion criteria may cause clinical heterogeneity. To visualize variation across studies, we grouped all eligible studies by underlying conditions and plotted the results using forest plots. We used different measures to quantify the variability of probability estimates across studies. I^2^ quantifies the percentage of variation that is not due to chance ([@R9]). While its use is well established in meta-analyses of effects of interventions ([@R9]), its value is unclear in other kind of reviews. For example, it is not recommended to be used in diagnostic test accuracy reviews ([@R10]). Tau^2^ is an estimate of between-study variance in random-effects meta-analyses. In our case, the term "effect" refers to the proportion of patients with a particular condition. To estimate tau^2^, we used the restricted maximum likelihood method. The interpretation of tau^2^ is not very intuitive, but it is a measure that allows the calculation of a prediction interval. The "true" proportion of a future study that is similar to those included in the analysis will lie within the prediction interval with a probability of 95% ([@R11]). Besides the number of studies, the width of the interval is determined by the heterogeneity across studies. We believe that it is a more intuitive measure of heterogeneity. For the statistical computations and displays we used the statistical software R 3.1.1 (Foundation for Statistical Analysis, Vienna, Austria) and the package meta ([@R12]).

Results
=======

Our initial search identified 1863 references ([Figure 1](#F1){ref-type="fig"}). After screening of titles and abstracts and comprehensive assessment of full papers we identified 31 references reporting data on 13 studies. One study reported data only on the prevalence of chest pain in primary care ([@R13]) and one study reported data only on two very broad categories of underlying conditions (organic etiology with and without signs) ([@R14]); both were therefore not considered in the current analysis. In total, we included 29 papers reporting data on 11 studies comprising about 6500 patients ([Table 1](#T1){ref-type="table"}). All studies were conducted in North-America or Europe between 1982 und 2010. The sex distribution across studies was reasonably homogeneous, with percentages of men in most studies ranging from 46% to 51%. In one small study (n = 51), the percentage of men was remarkably low (28%) ([@R15]). The studies varied somewhat with respect to the age limit. Five studies applied or reported no age limit ([@R16]-[@R20]). If reported, the percentage of children was low. In three studies the age limit varied between 16 and 20 years excluding children ([@R21]-[@R23]). Two studies included only patients aged ≥35 years ([@R6],[@R24]). A detailed description of methodological characteristics of the included studies and the details of risk of bias assessment are available in Supplementary material 2[(web extra material 2)](#S2){ref-type="supplementary-material"}. In six studies we rated the risk of bias in all three key domains as low ([Table 2](#T2){ref-type="table"}).
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###### 

Characteristics of studies and patients

  Study/ References\*        Country       Time of data collection   Setting                                                                              Number of patients   Age (mean, standard deviation)^†^                Male sex,%   Inclusion/exclusion criteria
  -------------------------- ------------- ------------------------- ------------------------------------------------------------------------------------ -------------------- ------------------------------------------------ ------------ ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Rosser 1990 (16)           Canada        1985                      109 general practitioners (GP) in 37 practices in 3 provinces                        832                  0-14: 1.2% 15-44: 34.1% 45-64: 32.6% 65+: 32.1   46.3         Chest pain as primary or secondary reason for encounter, no age limitation
  Sox 1990 (17)              USA           1982                      1 drop-in clinic                                                                     289                  41 (n.r.)                                        51           Chest pain as presenting complaint, no age limitation (ages were 17 to 81 years). Patients were excluded from this sample if they had not had at least two chest pain episodes that led to the index visit or if they had a final diagnosis of myocardial infarction (MI).
  Buntinx 1991 (18)          Belgium       1988                      25 GPs                                                                               318                  45 (19)                                          48           New episode of chest pain, discomfort or tightness as main or ancillary complaint, no age limitation
  Klinkman 1994 (21)         USA           1992-93                   11 primary care practices, Michigan                                                  392                  n.r^‡^                                           n.r^‡^       Adult patients who expressed chief complaint of chest pain or its equivalent. Only patients who were making their first visit in the particular episode were enrolled, patients seen elsewhere for an initial visit were excluded.
  Svavarsdottir 1996 (19)    Iceland       1989-90                   1 primary health care center                                                         190                  n.r.^§^                                          n.r.^§^      New episodes of chest pain, follow-up visits for the same episode were excluded, no age limitation mentioned, 6.3% were ≤20 years
  Katerndahl 1997 (15)       USA           1994-95                   8 family practice physicians, each from a different practice, South Texas            51                   42.6 (14.6)                                      28           Patients with a new complaint of chest pain, 18 years and older.
  Nilsson 2008 (22)          Sweden        1998-2000                 3 health care centers each served by 4 GPs                                           516                  54 (range 20-79)                                 49.6         New episode of chest pain, discomfort, or tightness as presenting complaint; aged 20-79 years; patients were excluded: if acute MI or coronary re-vascularization during the previous year
  Verdon 2008 (TOPIC) (23)   Switzerland   2001                      58 GPs in private practice                                                           672                  55 (19)                                          47.6         Chest pain as main or ancillary complaint; age ≥16 years
  Bruyninkx 2009 (20)        Belgium       2003                      GPs from all regions of the country covering almost 1.6% of the Belgian population   1996                 58.6 (18.1)                                      51.6         Patients consulting their GPs with non-traumatic chest pain, no age limitation mentioned.
  Bösner 2009 (6)            Germany       2004-05                   74 GPs in private practice, located in the state of Hesse                            1212                 59 (-)                                           44.1         Chest pain as main or ancillary complaint; age ≥35 years; excluded: chest pain ≥1 one month, or had already been investigated
  Haasenritter 2012 (24)     Germany       2009-10                   56 GPs in private practice, located in the state of Hesse                            856                  59.5 (13.9)                                      48.5         Chest pain as main or ancillary complaint; age ≥35 years; excluded: chest pain ≥1 one month, or had already been investigated

\*If several papers reported results on one study, we cited only the paper providing the most valuable information for the purpose of this review. However, all papers were comprehensively assessed and were cited in supplementary material 2[(web extra material 2)](#S2){ref-type="supplementary-material"}.

†Unless stated otherwise.

^‡^Authors stated that the age distribution of study patients closely approximated normal distribution, with a slight preponderance of younger adults, that slightly more women than men were included in the study, and that men were somewhat younger than women.

^§^Authors provided a figure displaying the age and sex distribution of patients. n.r.-- not reported.

###### 

Risk of bias

                            Domain                                                           
  ------------------------- ---------------------------------------------- ----------------- --------------------
  Study                     Selection of patients/ general practitioners   Data collection   Diagnostic work up
  Rosser 1990 (16)          low                                            low               high
  Sox 1990 (17)             low                                            low               low
  Buntinx 1991 (18)         low                                            low               low
  Klinkmann 1994 (21)       low                                            low               unclear
  Svavarsdottir 1996 (19)   high                                           unclear           unclear
  Katerndahl 1997 (15)      low                                            low               high
  Nilsson 2008 (22)         low                                            low               low
  Verdon 2008 (23)          low                                            low               low
  Bösner 2009 (6)           low                                            low               low
  Bruyninckx 2009 (20)      low                                            low               high
  Haasenritter 2012 (24)    low                                            low               low

The studies varied with respect to the number and definition of the considered underlying conditions. Three studies focused on coronary heart disease only ([@R17],[@R22],[@R24]). Among others, two studies provided data on the specific diagnoses of a wide range of underlying conditions ([@R18],[@R23]), while six studies provided data mainly on broader diagnostic categories. In several studies, the only specific condition addressed was coronary heart disease (acute and stable). We considered the following diagnostic categories: cardiovascular, gastrointestinal, esophageal, respiratory, and psychogenic disorders, chest wall syndrome and trauma. In addition, we considered one specific disease (acute and stable coronary heart disease).

Supplementary material 3[(web extra material 3)](#S3){ref-type="supplementary-material"} shows the forest plots for all diagnostic categories and conditions included in the analysis. For most of these diagnostic categories, we found substantial heterogeneity across studies indicated by high values of I^2^ and tau^2^ and by wide prediction intervals. Heterogeneity was in some cases moderately reduced by limiting the analysis to the studies with a low overall risk of bias ([Table 3](#T3){ref-type="table"}). Therefore, we decided to provide only a qualitative summary instead of pooled estimates.

###### 

Relative frequencies and measures of heterogeneity of different underlying conditions of chest pain in primary care considering only studies with a low overall risk of bias

  Study                                           N                             Percentage   95% confidence interval (CI)
  ----------------------------------------------- ----------------------------- ------------ ------------------------------
  Coronary heart disease (any)                                                               
  Buntinx 1991 (18)                               318                           9.7          6.8%-13.7%
  Nilsson 2008 (22)                               516                           11.8         9.2%-15.0%
  Verdon 2008 (23)                                672                           12.6         10.3%-15.5%
  Bösner 2009 (6)                                 1212                          14.8         12.8%-16.9%
  Haasenritter 2012 (24)                          856                           10.9         8.9%-13.2%
  Minimum-maximum                                 9.7%-14.8%                                 
  I^2^                                            60.4% (95% CI: 0.0%-85.2%)                 
  Tau^2^                                          0.02                                       
  Prediction interval                             7.7%-18.8%                                 
  Coronary heart disease (stable)                                                            
  Sox 1990 (17)                                   289                           8.0          5.2%-11.9%
  Buntinx 1991 (18)                               318                           6.6          4.2%-10.1%
  Verdon 2008 (23)                                672                           11.2         8.9%-13.8%
  Bösner 2009 (6)                                 1212                          11.1         9.5%-13.1%
  Haasenritter 2012 (24)                          856                           8.3          6.6%-10.4%
  Minimum-maximum                                 6.6%-11.2%                                 
  I^2^                                            62.8% (95% CI: 1.6%-86.0%)                 
  Tau^2^                                          0.03                                       
  Prediction interval                             4.9%-16.8%                                 
  Acute coronary syndrome/myocardial infarction                                              
  Buntinx 1991 (18)                               318                           3.1          1.6%-5.9%
  Verdon 2008 (23)                                672                           1.5          0.8%-2.8%
  Bösner 2009 (6)                                 1212                          3.6          2.7%-4.9%
  Haasenritter 2012 (24)                          856                           2.6          1.7%-3.9%
  Minimum-maximum                                 1.5%-3.6%                                  
  I^2^                                            58.6% (95% CI: 0.0%-86.2%)                 
  Tau^2^                                          0.08                                       
  Prediction interval                             0.6%-10.6%                                 
  Cardiovascular diseases                                                                    
  Buntinx 1991 (18)                               318                           13.8         10.3%-18.2%
  Verdon 2008 (23)                                672                           16.1         13.4%-19.1%
  Minimum-maximum                                 13.8%-16.1%                                
  I^2^                                            0% (95% CI: NA)                            
  Tau^2^                                          0                                          
  Prediction interval                             NA                                         
  Gastrointestinal disorders                                                                 
  Buntinx 1991 (18)                               318                           9.7          6.8%-13.7%
  Verdon 2008 (23)                                672                           8.2          6.3%-10.6%
  Bösner 2009 (6)                                 1212                          5.6          4.4%-7.1%
  Minimum-maximum                                 5.6%-9.7%                                  
  I^2^                                            76.7% (95% CI: 23.9%-92.9%)                
  Tau^2^                                          0.07                                       
  Prediction interval                             0.1%-82.6%                                 
  Esophageal disorders                                                                       
  Buntinx 1991 (18)                               318                           6.0          3.7%-9.3%
  Verdon 2008 (23)                                672                           7.1          5.4%-9.4%
  Minimum-maximum                                 6.0%-7.1%                                  
  I^2^                                            0% (95% CI: NA)                            
  Tau^2^                                          0                                          
  Prediction interval                             NA                                         
  Respiratory diseases                                                                       
  Buntinx 1991 (18)                               318                           18.2         14.2%-23.0%
  Verdon 2008 (23)                                672                           10.3         8.1%-12.9%
  Bösner 2009 (6)                                 1212                          12.0         10.3%-14.0%
  Minimum-maximum                                 10.3%-18.2%                                
  I^2^                                            84.2% (95% CI: 52.8%-94.7%)                
  Tau^2^                                          0.10                                       
  Prediction interval                             0.1%-94.0%                                 
  Psychogenic                                                                                
  Buntinx 1991 (18)                               318                           18.2         14.2%-23.0%
  Verdon 2008 (23)                                672                           11.5         9.2%-14.2%
  Bösner 2009 (6)                                 1212                          9.5          7.9%-11.3%
  Minimum-maximum                                 9.5%-18.2%                                 
  I^2^                                            89.3% (95% CI: 70.8%-96.0%)                
  Tau^2^                                          0.13                                       
  Prediction interval                             0.1%-97.0%                                 
  Chest wall syndrome                                                                        
  Buntinx 1991 (18)                               318                           24.5         20.0%-29.7%
  Verdon 2008 (23)                                672                           48.8         45.0%-52.7%
  Bösner 2009 (6)                                 1212                          49.8         47.0%-52.7%
  Minimum-maximum                                 24.5%-49.8%                                
  I^2^                                            96.9% (95% CI: 93.6%-98.5%)                
  Tau^2^                                          0.38                                       
  Prediction interval                             0.0%-100.0%                                
  Trauma                                                                                     
  Verdon 2008 (23)                                672                           3.9          2.6%-5.7%
  Bösner 2009 (6)                                 1212                          3.2          2.3%-4.4%
  Haasenritter 2012(24)                           856                           1.8          1.0%-2.9%
  Minimum-maximum                                 1.8%-3.9%                                  
  I^2^                                            68.6% (95% CI: 0.0%-90.9%)                 
  Tau^2^                                          0.11                                       
  Prediction interval                             0.0%-83.0%                                 

[Table 3](#T3){ref-type="table"} provides the results of the studies with a low overall risk of bias. We found that myocardial ischemia was the underlying condition of chest pain in 9.7 to 14.8% of chest pain cases. Stable CHD caused chest pain in 6.6%-11.2% of cases and acute coronary syndrome (ACS) or myocardial infarction (MI) in 1.5%-3.6% of cases. The relative frequencies of other conditions ranged from 24.5 to 49.8% (chest wall syndrome), 13.8 to 16.1% (cardiovascular diseases), 10.3 to 18.2% (respiratory diseases), 9.5 to 18.2% (psychogenic etiologies), 5.6 to 9.7% (gastrointestinal disorders), and 6.0 to 7.1% (esophageal disorders)

Discussion
==========

This systematic review identified 11 eligible studies investigating the causes of chest pain in the primary care setting comprising about 6500 patients. However, only 6 studies, comprising about 3900 patients, were methodologically sound and therefore appropriate to inform clinical practice.

To our best knowledge, this is the first review that systematically investigated the symptom of chest pain in primary care. Strengths of our study are the comprehensive search and the rigorous assessment of the risk of bias. Its limitations are the small number of studies and the heterogeneity across studies. Besides methodological reasons, this may be caused by different definitions of the diagnostic categories. However, our study gave important insight into the frequencies of relevant causes of chest pain in primary care and may be helpful for clinicians. Although they most likely do not deliberately reflect on it, GPs in their approach to chest pain patients apply probabilistic or Bayesian reasoning ([@R2]). In order to start the process of Bayesian arguing, they have to know the pre-test probabilities of different differential diagnoses.

The current review focuses on studies conducted in primary care. Our findings principally confirmed the results of Buntinx et al ([@R25]), who showed that there was a large difference in the diagnostic case mix presented in general practice compared with emergency departments or secondary care. In a previous systematic review on the accuracy of symptoms and signs for CHD we included 172 studies ([@R26]). The overwhelming majority of these studies recruited patients presenting with chest pain in secondary care or emergency departments. The percentage of cases with stable CHD as underlying condition was 52% (median) and the percentage of cases with ACS or MI as underlying condition was 37% (median). The relative frequencies of stable CHD and ACS/MI reported in primary care were distinctly lower.

Another reason why there is a need for robust data to describe the distribution for pre-test probabilities in chest pain patients is the fact that the diagnostic accuracy of consequently applied tests seems to vary with the underlying case mix ([@R27]). When they compared patients with chest pain in two high- and two low-disease prevalence populations, Sox et al ([@R17]) showed that patient history as a diagnostic test to estimate the probability of CHD did not show the same validity in both settings. Test accuracy of patient history and corresponding post-test probabilities for CHD depended on the prior probability of disease. These findings are supported by Knottnerus et al ([@R28]), who showed that the setting where a study was conducted influenced the characteristics of diagnostic tests. Therefore, it is important to provide exact data that reflect the different spectrum of disease in chest pain patients in primary care compared to the emergency department.

In conclusion, this review provided data on relative frequencies of several causes of chest pain in primary care. This knowledge may guide the initial diagnostic reasoning of clinicians when approaching chest pain patients in primary care. Because of unexplained heterogeneity, however, clinicians should use our results with caution. There is a need for large and methodologically sound studies investigating common symptoms in primary care. Ideally, these studies would not only determine the relative frequencies of all relevant differential diagnoses, but also investigate the diagnostic accuracy of symptoms, signs, and point-of-care tests considering the whole spectrum of relevant target diseases ([@R29]). Previously, a design for this kind of studies was suggested and discussed ([@R30]). The results could inform primary care health professionals how to effectively assess and triage patients presenting with particular symptoms.
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